Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Semaphorin 3A ELISA Kit (AC3851)
Cat.#: ASET-2440
Specifications
Description Rat Semaphorin 3A ELISA Kit allows for the in vitro quantitative determination of rat Semaphorin 3A concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.469 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.781-50 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1669 Mouse Cathepsin G ELISA Kit (AC3080) Quantitative inquiry ASET-2152 Human FGF19 ELISA Kit (AC3563) Quantitative inquiry ASET-2172 Human Parkin ELISA Kit (AC3583) Quantitative inquiry ASET-1061 Human ProSAAS ELISA Kit (AC2472) Quantitative inquiry ASET-2453 Human CLSTN1 ELISA Kit (AC3864) Quantitative inquiry ASET-2399 Human PITPNC1 ELISA Kit (AC3810) Quantitative inquiry ASET-2170 Rat Dopamine Receptor D1 ELISA Kit (AC3581) Quantitative inquiry ASET-2050 Human MAL ELISA Kit (AC3461) Quantitative inquiry ASET-1582 Canine beta Nerve Growth Factor ELISA Kit (AC2993) Quantitative inquiry ASET-2299 Human FGF13 ELISA Kit (AC3710) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket